^
abSasson S (January 1991). "Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor". Pathologie-Biologie. 39 (1): 59–69.
PMID2011412.
^
abBindal RD, Carlson KE, Reiner GC, Katzenellenbogen JA (October 1987). "11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor". Journal of Steroid Biochemistry. 28 (4): 361–370.
doi:
10.1016/0022-4731(87)91052-1.
PMID3669657.
^
abcRatajczak T, Atrache V, Antes P, Comber M, Hähnel R (1988). "A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors". Steroids. 51 (5–6): 499–518.
doi:
10.1016/0039-128x(88)90047-5.
PMID3242173.
S2CID11598932.
^
abcRatajczak T, Sheppard PN, Capon RJ, Hähnel R (November 1981). "The synthesis and study of some potential affinity labeling reagents for estrogen receptors". Steroids. 38 (5): 537–555.
doi:
10.1016/0039-128x(81)90053-2.
PMID7324085.
S2CID37503105.
^
abQuivy J, Leclercq G, Deblaton M, Henrot P, Velings N, Norberg B, et al. (September 1996). "Synthesis, structure and biological properties of Z-17alpha-(2-iodovinyl)-11beta-chloromethyl estradiol-17beta (Z-CMIV), a high affinity ligand for the characterization of estrogen receptor-positive tumors". The Journal of Steroid Biochemistry and Molecular Biology. 59 (1): 103–117.
doi:
10.1016/s0960-0760(96)00007-6.
PMID9009243.
S2CID54359888.
^
abSasson S (January 1991). "Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor". Pathologie-Biologie. 39 (1): 59–69.
PMID2011412.
^
abBindal RD, Carlson KE, Reiner GC, Katzenellenbogen JA (October 1987). "11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor". Journal of Steroid Biochemistry. 28 (4): 361–370.
doi:
10.1016/0022-4731(87)91052-1.
PMID3669657.
^
abcRatajczak T, Atrache V, Antes P, Comber M, Hähnel R (1988). "A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors". Steroids. 51 (5–6): 499–518.
doi:
10.1016/0039-128x(88)90047-5.
PMID3242173.
S2CID11598932.
^
abcRatajczak T, Sheppard PN, Capon RJ, Hähnel R (November 1981). "The synthesis and study of some potential affinity labeling reagents for estrogen receptors". Steroids. 38 (5): 537–555.
doi:
10.1016/0039-128x(81)90053-2.
PMID7324085.
S2CID37503105.
^
abQuivy J, Leclercq G, Deblaton M, Henrot P, Velings N, Norberg B, et al. (September 1996). "Synthesis, structure and biological properties of Z-17alpha-(2-iodovinyl)-11beta-chloromethyl estradiol-17beta (Z-CMIV), a high affinity ligand for the characterization of estrogen receptor-positive tumors". The Journal of Steroid Biochemistry and Molecular Biology. 59 (1): 103–117.
doi:
10.1016/s0960-0760(96)00007-6.
PMID9009243.
S2CID54359888.